tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRRK Stock Latest News

Scholar Rock price target lowered to $51 from $52 at Piper Sandler
The FlyScholar Rock price target lowered to $51 from $52 at Piper Sandler
7d ago
SRRK
Optimistic Outlook for Scholar Rock Holdings Amid Regulatory Challenges
PremiumRatings
Optimistic Outlook for Scholar Rock Holdings Amid Regulatory Challenges
7d ago
SRRK
Scholar Rock price target lowered to $44 from $45 at Barclays
PremiumThe Fly
Scholar Rock price target lowered to $44 from $45 at Barclays
7d ago
SRRK
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
7d ago
HD
ACN
Scholar Rock price target lowered to $44 from $50 at H.C. Wainwright
PremiumThe Fly
Scholar Rock price target lowered to $44 from $50 at H.C. Wainwright
8d ago
NVO
SRRK
Buy Rating for Scholar Rock Holding: Clinical Promise and Financial Stability Amid Manufacturing Delay
PremiumRatingsBuy Rating for Scholar Rock Holding: Clinical Promise and Financial Stability Amid Manufacturing Delay
8d ago
SRRK
Scholar Rock Stock (SRRK) Puts on the Pounds Despite Muscle Drug Blow
Premium
Market News
Scholar Rock Stock (SRRK) Puts on the Pounds Despite Muscle Drug Blow
8d ago
NVO
REGN
Morning Movers: Boeing up as lawmakers talk up deal for China to buy more jets
Premium
The Fly
Morning Movers: Boeing up as lawmakers talk up deal for China to buy more jets
8d ago
BA
LB
Scholar Rock Faces FDA Setback for Apitegromab
PremiumCompany Announcements
Scholar Rock Faces FDA Setback for Apitegromab
8d ago
8K
SRRK
Scholar Rock receives CRL from FDA for apitegromab BLA
PremiumThe Fly
Scholar Rock receives CRL from FDA for apitegromab BLA
8d ago
NVO
SRRK
Scholar Rock initiated with an Overweight at Barclays
PremiumThe Fly
Scholar Rock initiated with an Overweight at Barclays
14d ago
SRRK
Scholar Rock initiated with an Overweight at Barclays
PremiumThe Fly
Scholar Rock initiated with an Overweight at Barclays
14d ago
SRRK
Scholar Rock initiated with an Outperform at Leerink
PremiumThe FlyScholar Rock initiated with an Outperform at Leerink
16d ago
SRRK
Scholar Rock assumed with a Buy at Jefferies
Premium
The Fly
Scholar Rock assumed with a Buy at Jefferies
1M ago
SRRK
Scholar Rock publishes SAPPHIRE trial data in The Lancet
Premium
The Fly
Scholar Rock publishes SAPPHIRE trial data in The Lancet
2M ago
SRRK
Positive Outlook on Scholar Rock Holdings Due to Innovative Therapies and Strategic Advancements
PremiumRatings
Positive Outlook on Scholar Rock Holdings Due to Innovative Therapies and Strategic Advancements
2M ago
SRRK
Scholar Rock’s Optimistic Earnings Call Highlights Progress
PremiumCompany Announcements
Scholar Rock’s Optimistic Earnings Call Highlights Progress
2M ago
SRRK
Scholar Rock Reports Q2 2025 Progress and Financials
PremiumCompany Announcements
Scholar Rock Reports Q2 2025 Progress and Financials
2M ago
SRRK
Optimistic Buy Rating for Scholar Rock Amid Apitegromab’s Promising FDA Review and Market Expansion Potential
PremiumRatings
Optimistic Buy Rating for Scholar Rock Amid Apitegromab’s Promising FDA Review and Market Expansion Potential
2M ago
SRRK
Scholar Rock reports Q2 EPS (98c), consensus (67c)
PremiumThe FlyScholar Rock reports Q2 EPS (98c), consensus (67c)
2M ago
SRRK
Scholar Rock’s Apitegromab Receives FDA Priority Review
Premium
Company Announcements
Scholar Rock’s Apitegromab Receives FDA Priority Review
2M ago
8K
SRRK
Scholar Rock assumed with a Strong Buy at Raymond James
Premium
The Fly
Scholar Rock assumed with a Strong Buy at Raymond James
2M ago
SRRK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >